Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
NCT ID: NCT04722120
Last Updated: 2022-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2016-06-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction
NCT04027556
Comparison Between LDCT With DL Recontruction and Standard Dose CT
NCT05324046
"Double Low-Dose" DECT for HCC Imaging
NCT03045445
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
NCT03731910
Liver CT Dose Reduction With Deep Learning Based Reconstruction
NCT05804799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional liver CT
Underwent conventional liver CT on HCC high-risk patient
Conventional CT (radiation)
Underwent liver CT without change of radiation.
Conventional CT (contrast agent)
Underwent liver CT without change of contrast media doses.
Double low dose CT
Underwent double low dose liver CT with 30% lower radiation dose and 20% contrast media on HCC high-risk patient
Low radiation dose CT
Underwent liver CT with 30% lower radiation dose
Low contrast dose CT
Underwent liver CT 20% lower dose contrast media.
Deep-learning based contrast boosting algorithms
Applied deep-learning based contrast boosting algorithms on acquired CT images
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low radiation dose CT
Underwent liver CT with 30% lower radiation dose
Conventional CT (radiation)
Underwent liver CT without change of radiation.
Low contrast dose CT
Underwent liver CT 20% lower dose contrast media.
Conventional CT (contrast agent)
Underwent liver CT without change of contrast media doses.
Deep-learning based contrast boosting algorithms
Applied deep-learning based contrast boosting algorithms on acquired CT images
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tumor marker (aFP, PIVKA) elevation
* Nodular lesion on USG
* Received RFA for HCC
Exclusion Criteria
* GFR under 30
* BMI over 30
* Nursing or pregnant women
* enrolled the other study
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeong Min Lee
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeong Min Lee, MD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUH-2016-2272
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.